Media Release - ad hoc announcement pursuant to Art. 53 LR PolyPeptide Group appoints Neil Thompson as Director Global Sales and Marketing and member of the Executive Committee, succeeding Jan Christensen Zug, December 1, 2021 - PolyPeptide Group AG, a global leader in peptide development and manufacturing, today announced the appointment of Neil [ … ]

Media Release Ad hoc announcement pursuant to Art. 53 LR Results of Accelerated Bookbuild Offering of 1,500,000 Existing Shares in PolyPeptide Group AG Zug, 10 November 2021 - PolyPeptide Group AG ("PolyPeptide") has been informed that Draupnir Holding B.V. ("Draupnir"), which held 60.0% of PolyPeptide's share capital as of close of trading on S [ … ]

Media Release - ad hoc announcement pursuant to Art. 53 LR PolyPeptide reports strong H1 2021 revenue growth and operating leverage amidst favorable market environment and encouraging business trends Zug, 17 August 2021 - PolyPeptide Group AG (SIX: PPGN), a global leader in peptide custom development and manufacturing, today announced its results [ … ]

Media Release - ad hoc announcement pursuant to Art. 53 LR PolyPeptide Group appoints Christina Del Vecchio as General Counsel and member of the Executive Committee Zug, 25 June 2021 - PolyPeptide Group AG, a global leader in peptide development and manufacturing, today announced the appointment of Christina Del Vecchio as General Counsel and mem [ … ]

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN THE UNITED STATES OF AMERICA, CANADA, JAPAN OR AUSTRALIA OR ANY OTHER JURISDICTION IN WHICH THE DISTRIBUTION OR RELEASE WOULD BE UNLAWFUL. FOR RELEASE IN SWITZERLAND - THIS IS A RESTRICTED COMMUNICATION AND YOU MUST NOT FORWARD IT OR ITS CONTENTS TO ANY PE [ … ]